Physician profile
Samuel E Cress
NPI 1942421904
$742.82
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $256 · 2021: $190 · 2022: $153.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $201.61 | 2019-2020 | |
| Hu-Friedy Mfg. Co., LLC | $189.69 | 2021 | |
| Dental Health Products, INC. | $150.15 | 2020 | |
| Geistlich Pharma, North America, INC. | $26.57 | 2020 | |
| Philips North America LLC | $11.37 | 2020 | |
| Ivoclar Vivadent, INC. | $10.37 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Cress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.